Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Envoy Medical got FDA go-ahead to advance its fully implanted cochlear implant trial, based on positive early results.
Envoy Medical received FDA approval to move its pivotal trial for the fully implanted Acclaim cochlear implant to the final stage, based on positive three-month data from 10 patients with no serious adverse events.
The approval accelerates the timeline by three to six months, with full enrollment now expected by early 2026.
The company also reduced its capital needs by $10–15 million due to faster progress and improved efficiency, retired $32 million in debt, and announced board changes, including the departure of Glen Taylor after 20 years.
3 Articles
Envoy Medical obtuvo el visto bueno de la FDA para avanzar en su ensayo de implante coclear totalmente implantado, basado en resultados positivos tempranos.